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The timely recognition of dementia is the prerequisite
for adequate information, treatment, and care. Neverthe-
less, dementia is known to be considerably underdiag-
nosed; even in high-income countries with advanced
medical care systems about 50% to 80% of people withimer’s Association. This is an open access article under the CC BY-NC-ND
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are approaches to improve the recognition of dementia,
such as the proactive “dementia case finding scheme”
that was initiated by the government of the United
Kingdom [3] or the “Annual Wellness Visit” for Medicare
enrollees in the United States which includes the detection
of any cognitive impairment [4]. However, the best practice
for the identification of dementia in primary care has not
yet been established. Previous studies showed that the
use of structured screening instruments improves the iden-
tification of cognitive impairment in primary care and that
the screening for dementia increases diagnosis rates [5–7].
Nevertheless, routine screening is controversially discussed
and not recommended in respective dementia guidelines
because there is still a lack of evidence that patients
benefit from it [8–12]. Arguments against routine
screening include the risk of receiving a false-positive
diagnosis of dementia after a positive screening outcome;
the cause of anxiety or depression among positively
screened subjects; unnecessary examinations and treat-
ments; the diversion of resources that would better be
used to care for real dementia cases; or the danger that
older patients will avoid visiting their general practitioner
(GP) because they fear to be diagnosed with dementia
[13–16]. Therefore, routine screening of asymptomatic
patients is not seen as the favorable solution to improve
the recognition of patients with dementia in primary care.
It has been suggested that the case-finding of dementia
should focus on patients presenting with cognitive com-
plaints [14,15].
Subjective memory impairment (SMI) may represent the
first symptomatic manifestation of Alzheimer’s disease and
SMI and related worries have been identified as risk factors
for the incidence of dementia in people without objective
cognitive impairment [17–19]. However, the diagnostic
value of self-reported cognitive impairment for prevalent de-
mentia seems to be limited for several reasons: SMI is asso-
ciated with depression [20–22]; cognitively healthy older
persons frequently complain about memory impairment
[23,24]; and PWD are often not aware of their memory
problems [25,26].
Mitchell [27] conducted a meta-analysis of the diag-
nostic value of subjective memory complaints for mani-
fest dementia in community samples with a low
prevalence of dementia and found a positive predictive
value (PPV) of 19% and a negative predictive value
(NPV) of 94%. Mitchell concludes that the absence of
subjective memory complaints may be a reasonable
method of excluding dementia and could be incorporated
into short screening programs in settings with low preva-
lence of dementia. However, to our knowledge this
assumption has not yet been validated in clinical settings.
This study aims to determine whether self-reported SMI
or SMI-related worries could be used as a valid criteria
to decide if an elderly primary care patient should be
screened for dementia.Therefore, we want to determine (1) the diagnostic value
and (2) the predictive ability of self-reported SMI and related
worries for the discrimination of patients with and without
cognitive impairment (i.e. patients screened positive and
negative for dementia).2. Methods
2.1. Study design
The present cross-sectional analyses are based on data
derived from the ongoing German GP-based, randomized,
controlled intervention trial DelpHi-MV (dementia: life-
and person-centered help in Mecklenburg, Western Pomer-
ania). The details of the study are described elsewhere
[28–30]. The eligible patients (70 years, living at
home) in participating GP practices are asked by the GP
or the assistant whether they experience SMI and if so,
whether they worry about their SMI. After the patients
answered these questions they are screened for dementia
using DemTect [31], which is a widely used dementia
screening test in GP practices in Germany [32]. The Dem-
Tect score,9 is the inclusion criteria for the DelpHi-trial.
Present analyses are based on the larger pool of patients
tested for eligibility of the clinical trial. The patients who
meet the inclusion criteria for DelpHi-MV are informed
by their GPs about the study, invited to participate, and
asked to provide written informed consent. When the pa-
tient is unable to give a written informed consent, his or
her legal representative is asked to sign the consent form
on his or her behalf (as approved by the Ethical Committee
of the Chamber of Physicians of Mecklenburg, Western
Pomerania, registry number BB 20/11). To compensate
for their additional effort, study physicians receive an
allowance for each screening (10V per patient) and an
additional allowance for the inclusion of patients in the
trial (100V per patient).
2.2. Study population
Of 5511 eligible patients (age 70 years, living at home)
screened for dementia in 110 participating GP practices
(November 2011 to August 2014) we included 5106 patients
with complete data regarding age, sex, DemTect-score, and
self-reported SMI into the analyses. A total of 406 patients
were excluded of the analyses because of missing data in
the variables sex (n5 16) and SMI (n5 389). For the anal-
ysis of SMI-related worries we included 2480 patients who
reported the presence of SMI and responded to the question
for SMI-related worries.
2.3. Procedures and instruments
For sample description we analyzed age, sex, DemTect-
score, self-reported SMI, and related worries. DemTect
[31] is a personal interview-based instrument that includes
five tasks (recall of word list, number transcoding task,
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list). It is a highly sensitive screening test to identify people
with dementia in the early stage of the disease (sensitivity
was 80% for detecting MCI and 100% for Alzheimer’s dis-
ease). The total DemTect-score ranges from 0 to18, a total
score,9 indicates dementia. SMI (“Do you have memory
problems?”) and SMI-related worries (“Do you worry about
your memory problems?”) were analyzed as dichotomized
variables (yes/no).2.4. Statistical analyses
We summarized the variables that describe the sample
using descriptive statistics. To test for differences
between positively and negatively screened patients we
used nonparametric tests (two-sample Wilcoxon rank-
sum test for continuous and Pearson’s chi2-test for
categorized variables with a 5 0.05). To determine the
diagnostic value of SMI and SMI-related worries we
calculated the sensitivity (percent of positively screened
patients with dementia who reported SMI/SMI-related
worries); the specificity (percent of negatively screened
patients who did not report SMI/SMI-related worries);
the PPV (percent of patients reporting SMI with positive
screening outcome); and the NPV (percent of patients not
reporting SMI with negative screening outcome). To
compare our results with the outcomes of the meta-
analyses of Mitchell [27], we calculated the clinical util-
ity index (UI). The predictive value is heavily influenced
by the prevalence, whereas the utility index combines
discriminatory ability (sensitivity/specificity) and occur-
rence (PPV/NPV). The positive utility index (UI1) as a
measure of “rule-in accuracy” is a product of sensitivity
and PPV; the negative utility index (UI2) as a measure
of “rule-out accuracy” is a product of specificity and
NPV. The UI can be considered a measure of the clinical
value of a diagnostic test and is interpreted as follows:
,0.2 poor; .0.2  0.4 fair; .0.4  0.6 moderate;
.0.6  0.8 good; and .0.8  1.0 very good.
We provide subgroup analyses by age (5-year intervals)
and sex as supplemental material.
To determine the predictive ability of SMI and related
worries we performed receiver operating characteristics
(ROC) analyses which test whether the addition of a term
for SMI/SMI-related worries increases the AUC enoughTable 1
Sociodemographic and clinical characteristics of the study sample
Total sample
(N 5 5106)
Patients s
negative
Sex (female), n (%) 3059 (60) 2543 (60
Age (yrs), mean (SD) 77.80 (0.73) 77.22 (0.
DemTect, mean (SD) 12.35 (0.06) 13.72 (0.
Abbreviation: SD, standard deviation.
*Pearson’s chi2-test.
yWilcoxon rank-sum test.to justify its inclusion in the models with age and sex.
Age and female sex are important risk factors for dementia
[10] that are easy to observe in a GP practice. To test for
possible interaction between SMI/SMI-related worries
and sex or age we fitted additionally logistic models
including corresponding multiplicative interaction terms,
but neither interaction term was statistically significant.
Because of the large sample we conducted stratified ROC
analyses to examine the efficiency of SMI and related
worries for both sexes. Statistical analyses were performed
by STATA/IC [33].3. Results
3.1. Sociodemographic and clinical characteristics
Table 1 presents the sociodemographic and clinical char-
acteristics of the study sample.3.2. Diagnostic value of SMI and SMI-related worries
A total of 5106 patients (70 years) were screened for
dementia; and 50% of these patients reported the presence
of SMI. Seventeen percent of all patients were screened pos-
itive for dementia (n 5 892).
Before the screening, 46% of the positively screened pa-
tients had stated that they had not experienced SMI. On the
other hand, 49% of the negatively screened patients had
stated that they had experienced SMI. The sensitivity, spec-
ificity, the predictive value, and the UI for SMI are shown in
Table 2.
Subgroup analyses for SMI (by age and sex) are provided
in Supplemental Table 1. Across the different age groups the
sensitivity of SMI ranged between 54% and 58% (female)
and 47% and 65% (male); the specificity ranged between
39% and 52% (female) and 41% and 53% (male). The
PPV (range: 6%–38%) as well as the UI1 (range 0.03–
0.23) were lowest in the youngest age group and increased
with age. The NPV (range: 60%–95%) and the UI2 (range:
0.23–0.49) were highest in the youngest age group and
decreased with age.
Among 2480 patients that reported SMI, 45% stated that
they worried about their SMI. SMI-related worries were
indicated by 52% of the patients screened positive and
43% of the patients screened negative for dementia.creened
(n 5 4214)
Patients screened
positive (n 5 892) P value
) 516 (57) .167*
08) 80.51 (0.19) ,.001y
43) 5.91 (0.08) –
Table 2
Subjective memory impairment and related worries among patients screened negative and positive for dementia: sensitivity, specificity, predictive value, and
clinical utility index
Total sample
Patients screened
negative
Patients screened
positive Sensitivity Specificity PPV NPV UI1 UI2
Total, n 5106 4214 892
No SMI 2550 (50%) 2142 (51%) 408 (46%) 54% 51% 19% 84% 0.10 (poor) 0.43 (moderate)
SMI 2556 (50%) 2072 (49%) 484 (54%)
Total, n 2480 2011 469
No worries 1362 (55%) 1138 (57%) 224 (48%) 52% 57% 22% 84% 0.11 (poor) 0.47 (moderate)
Worries 1118 (45%) 873 (43%) 245 (52%)
Abbreviations: SMI, subjective memory impairment; PPV, positive predictive value; NPV, negative predictive value; UI1, positive utility index; UI2, nega-
tive utility index.
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value, and the UI for SMI-related worries.
Subgroup analyses for SMI-related worries (by age and
sex) are provided in Supplemental Table 2. Across the
different age groups the sensitivity ranged between 39%
and 70% (female) and 30% and 46% (male); the specificity
ranged between 54% and 64% (female) and 54% and 80%
(male). The PPV (range: 11%–39%) and the UI1 (range
0.04–0.20) were lowest in the youngest age group and
increased with age. The NPV (range: 68%–97%) and the
UI2 (range: 0.37–0.73) were highest in the youngest age
group and decreased with age.3.3. Predictive ability of SMI and SMI-related worries
The results of the ROC analyses are shown in Table 3.
Regarding the discrimination of positively and negativelyTable 3
ROC analyses for predictive models with and without subjective memory
impairment and related worries
Observations AUC SE
95%
confidence
interval Chi2
P
value
Total
Age, sex 5016 0.678 0.010 0.660 0.697 0.18 .669
Age, sex, SMI 5016 0.678 0.010 0.659 0.697
Female patients
Age 3059 0.703 0.012 0.679 0.727 0.22 .638
Age, SMI 3059 0.705 0.012 0.681 0.728
Male patients
Age 2047 0.637 0.016 0.606 0.668 0.06 .804
Age, SMI 2047 0.637 0.016 0.606 0.668
Total
Age, sex 2480 0.678 0.013 0.652 0.705 1.60 .207
Age, sex,
worries
2480 0.684 0.013 0.658 0.710
Female patients
Age 1491 0.697 0.017 0.664 0.730 0.22 .638
Age, worries 1491 0.700 0.016 0.668 0.732
Male patients
Age 989 0.648 0.022 0.604 0.709 3.45 .063
Age, worries 989 0.666 0.022 0.623 0.709
Abbreviations: ROC, receiver operator curve; AUC, area under the curve;
SE, standard error; SMI, subjective memory impairment.screened patients there were no statistically significant dif-
ferences between the AUCs when using SMI or SMI-
related worries as predictors additional to age and sex (see
Fig. 1A and B).
Stratified analyses revealed that AUCs did not improve
statistically significantly when SMI or SMI-related worries
were included as predictors rather than just age, neither for
female nor for male patients (see Table 3).4. Discussion
This study aimed to determine whether self-reported sub-
jective memory impairment or related worries could be used
as a suitable criteria for case-finding of dementia in elderly
primary care patients.
Our analyses showed that the sensitivity of SMI was just
54%. This means that 46% of the primary care patients
screened positive for dementia did not report SMI before
the screening. Thus almost half of the patients with cognitive
impairment would have been overlooked if the presence of
SMI would have been the precondition for performing the
structured cognitive test. In addition, both the PPV (19%)
and the UI1 (0.10; interpreted as “poor” rule-in-accuracy)
of SMI were very low. Mitchell [27] reported similar results
with a meta-analytic pooled sensitivity of 43%, a PPV of
19%, and an UI1 of 0.08 and concluded that “subjective
memory complaints should not be relied on for case-
finding”. These findings are in line with the results of previ-
ous studies that showed that people with dementia are often
not aware of their memory problems [25,26].
On the other hand, 49% of all patients who had screened
negative for dementia in the present sample stated that they
experience SMI. The specificity of SMI was just 51%, the
NPV was 84%, and the UI2 was 0.43 (moderate). These re-
sults agree with the outcomes of previous studies showing
that cognitively healthy older persons often complain about
memory impairment [23,24]. Because the present cross-
sectional analyses are based on prevalent cases, our results
are unrelated to the use of SMI as a predictor for the risk
of future development of dementia in patients without objec-
tive cognitive impairment [17–19]. We are not able to
determine whether SMI-positive, but DemTect-negative
Fig. 1. (A) Receiver operating characteristics (ROCs) for models with and without subjective memory impairment. (B) ROCs for models with and without
subjective memory impairment-related worries.
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mentia in the future.
For SMI-related worries, we found similar results: the
sensitivity (53%), the specificity (57%), the PPV (22%),
and the UI1 (0.11) were very low. If the presence of SMI
in conjunction with SMI-related worries would have been
the preselecting criteria for further cognitive testing, evenmore than 70% of the positively screened patients would
not have been tested for cognitive impairment.
Subgroup analysis by age and sex showed some inconsis-
tent differences in the sensitivity and specificity of SMI and
SMI-related worries across the age groups and between male
and female patients. The “rule-in accuracy” (PPV/UI1)
increased with age, whereas the “rule-out accuracy” (NPV/
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extend) the UI are influenced by the age-related increase of
the prevalence of dementia. Although the diagnostic value of
SMI or SMI-related worries was for some subgroups better
than for the total sample, the subgroup differences were
rather inconsistent. Therefore our results do not allow iden-
tifying specific subgroups for which the presence of SMI or
related worries would be suitable as preselection criteria for
the case finding of dementia.
ROC analyses showed that the AUCs of the models that
included just age and sex as predictors for a positive
screening outcome differed only marginally from the models
that included SMI or related worries as additional predictors.
Despite the large sample size, the analyses showed no statis-
tically significant improvement in the AUCs. If interpreting
the statistics one-sided, there was a significant improvement
when using SMI-related worries as predictor in addition to
age in male patients. The statistical approach of comparing
AUCs of nested models (as done in the present study) is
known to lead to overly conservative P-values [34]; there-
fore P-values have to be treated with care.
Overall, the predictive ability cannot be considered satis-
factory. Our results indicate that neither SMI nor related
worries discriminated adequately between patients screened
positive or negative for dementia. These results are consis-
tent with the findings of previous studies that showed that
self-reported memory problems correlate poorly with the
present psychometric impairment [20,22,24].
Mitchell [27] reported a NPVof 94% and a UI2 of 0.77
(interpreted as good) in community samples. He assumed
that the absence of subjective memory complaints may be
a reasonable method of excluding dementia and could be
used as a preselection criteria in screening programs for de-
mentia in settings with low prevalence of dementia. To our
knowledge, this is the first study that has examined this hy-
pothesis in a large sample of elderly primary care patients. In
our sample we found lower values, the NPV was 84%; and
the UI2 0.43 (interpreted as “moderate” rule-out-
accuracy). A reason for these differences might be the higher
prevalence of dementia in primary care practices than in
community samples. In our sample, the prevalence of posi-
tively screened patients was 17%. This is similar to the find-
ings of a study in Seattle (USA), where 18% of 524 primary
care patients (aged 651) screened positive for dementia [6].
To conclude, our results provide clear evidence that in
neither SMI nor related worries can be used as valid criteria
to decide whether an elderly primary care patient should be
tested for dementia or not. The risk of overlooking cognitive
impairment in the subgroup of patients who state that they do
not experience SMI or related worries would be unreason-
able high.
For the current clinical practice our results indicate that it
is not sufficient to examine only those patients for dementia
who are complaining about memory problems. Physicians
should apply more appropriate methods to ensure the timely
recognition of dementia.In contrast to self-reported SMI, the evaluation of cogni-
tive impairment by informants may be a more reliable pre-
dictor for cognitive impairment. Carr et al. [24] showed
that informants were able to identify 92% of those subjects
judged by the clinician to have dementia. However, many
older people live alone and visit their GP unaccompanied,
thus an informant is often not available.
Recently, the Alzheimer’s Association International pro-
posed an algorithm to detect cognitive impairment during
the Medicare “Annual Wellness Visit” in a primary care
setting that addresses the problem of the unreliability of
self-reported SMI and the unavailability of informants:
whenever signs of cognitive impairment are self-reported
by the patient or noted by the clinician, a brief structured
assessment should be performed. In case there is no infor-
mant present to provide confirmatory information, the brief
structured assessment should be performed anyway. A pos-
itive screening outcome triggers further full dementia evalu-
ation [4]. Further studies should evaluate whether this
algorithm would permit a more reliable case-finding of de-
mentia in primary care, because the timely identification
of people with dementia is a major unsolved problem in de-
mentia care [1,2].Acknowledgments
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1. Systematic review: We searched PubMed for articles
with the following search terms: dementia and sub-
jective memory impairment; subjective memory
complaints; subjective cognitive decline; related
worries; screening, case-finding; and primary care.
In addition we reviewed the reference lists of articles
identified.
2. Interpretation: It has been assumed that the absence
of subjective memory impairment (SMI) may be a
reasonable method of excluding dementia and could
be incorporated as a preselection criterion into short
screening programs. Present results provide evidence
that SMI cannot be used as a valid criteria to decide
whether an elderly primary care patient should be
screened for dementia. The risk of overlooking
cognitive impairment in the subgroup of patients
who state that they do not experience SMI would
be unreasonable high.
3. Future directions: Further studies should evaluate
whether the additional assessment of cognitive
impairment by informants would permit a more reli-
able case-finding of dementia in primary care.References
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